Top Story

Mohs micrographic surgery may effectively treat rare hidradenocarcinoma

March 5, 2015

Mohs micrographic surgery was an effective long-term treatment for patients with hidradenocarcinoma, according to study results.

Researchers retrospectively evaluated the charts of patients with hidradenocarcinoma (HAC), a rare malignant adnexal neoplasm, treated with Mohs micrographic surgery (MMS) at the Mayo Clinic from 1993 to 2013. Data on patient demographics, tumor characteristics, MMS stages to clearance, follow-up, recurrence, metastasis and mortality were collected.

In the Journals

Patient characteristics linked to degree of family involvement in treatment decisions

March 5, 2015
A majority of patients recently diagnosed with lung or colorectal cancers chose to include family members in treatment-related decisions, according to study…
In the Journals

ADT increases risk for cardiovascular disease in men with prostate cancer

March 5, 2015
Patients with prostate cancer who received androgen-deprivation therapy demonstrated an increased risk for cardiovascular disease, according to study results.Men with a…
Guido Marcucci, MD Institution Notes

Physician-researcher joins City of Hope

March 5, 2015
Guido Marcucci, MD, a renowned physician and researcher, has accepted a leadership appointment at City of Hope’s new Hematologic Malignancies and Stem Cell…
Industry News

NCI director to step down March 31

March 5, 2015
Harold Varmus, MD, who has served as director of the NCI for the past 5 years, will step down at the end of this month.“I take this step with a mixture of regret…
More News Headlines »
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
thumbnail for video 4040847621001

MET targeting, PD-L1/PD-1 inhibition highlight recent developments in genitourinary oncology

February 11, 2015
Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, president of Levine Cancer Institute at Carolinas HealthCare System and…
More »
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »